Brian Anderson

About the Author Brian Anderson


Analysts Offer Insights on Healthcare Companies: Medtronic (MDT) and Crispr Therapeutics AG (CRSP)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medtronic (MDT) and Crispr Therapeutics …

Guggenheim Keeps a Buy Rating on Kohl’s (KSS)

In a report released today, Robert Drbul from Guggenheim maintained a Buy rating on Kohl’s (KSS), with a price target of $58.00.

Athenex (ATNX) Gets a Buy Rating from Needham

In a report released today, Chad Messer from Needham reiterated a Buy rating on Athenex (ATNX), with a price target of $30.00.

Barrington Maintains Their Hold Rating on Copart (CPRT)

Barrington analyst Gary Prestopino maintained a Hold rating on Copart (CPRT) today. The company’s shares closed last Monday at $86.

Analysts Conflicted on These Financial Names: One Liberty Properties (OLP) and Ellington Financial (EFC)

Analysts have been eager to weigh in on the Financial sector with new ratings on One Liberty Properties (OLP) and Ellington Financial (EFC). …

Dicerna Pharma (DRNA) Gets a Buy Rating from H.C. Wainwright

In a report released today, Ed Arce from H.C.

Positive Report for Audentes Therapeutics (BOLD) from Evercore ISI

Evercore ISI analyst Joshua Schimmer upgraded Audentes Therapeutics (BOLD) to Buy today and set a price target of $40.00.

H.C. Wainwright Keeps Their Buy Rating on Iterum Therapeutics (ITRM)

In a report released yesterday, Ed Arce from H.C.

Needham Reaffirms Their Buy Rating on Phasebio Pharmaceuticals (PHAS)

In a report released yesterday, Chad Messer from Needham reiterated a Buy rating on Phasebio Pharmaceuticals (PHAS), with a price target of $20.00.

Analysts Are Bullish on Top Materials Stocks: Newmont Mining (NEM), Pan American Silver (PAAS)

There’s a lot to be optimistic about in the Materials sector as 3 analysts just weighed in on Newmont Mining (NEM), Pan American …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts